Ryan Sun

Ryan Sun is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research integrates oncology, cancer immunotherapy, radiation oncology, and pathology, with a focus on clinical trial design, CAR-T therapy outcomes, and tumor microenvironment dynamics. Recent work includes identifying optimal absolute lymphocyte counts at leukapheresis for lymphoma patients, characterizing STAT3 transcriptome signatures in colorectal cancer progression, and analyzing pleiotropic genetic risk variants linking pancreatic cancer and diabetes. He also leads the WOLVERINE meta-analysis of oligometastatic prostate cancer trials and has published on venous thromboembolism in aggressive B-cell lymphoma patients receiving CD19 CAR-T therapy. His contributions span high-impact venues including Cancer Cell, Journal of Clinical Oncology, and Laboratory Investigation.